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Background: The aim of this study was to determine the association between 25-hydroxyvitamin D (25-OHD) levels
at the onset of critical illness and the development of acute lung injury/acute respiratory distress syndrome
(ALI/ARDS) in patients with sepsis or trauma.
Methods: We performed two nested case-control studies of 478 patients with sepsis and trauma with or without
ALI/ARDS admitted to the medical, surgical and trauma ICUs of a tertiary-care center. Cases consisted of patients
with either sepsis or trauma and ALI/ARDS; controls consisted of equivalent numbers of matched patients with
either sepsis or trauma alone. We measured serum 25-OHD levels the morning after ICU admission and used
multivariable regression to assess the relationship between 25-OHD and diagnosis of ALI/ARDS during the first four
ICU days, controlling for age, gender, diabetes, smoking status and season.
Results: 25-OHD levels did not differ between cases with ALI/ARDS and controls in either the sepsis or trauma
cohorts. Using a conditional logistic regression model, sepsis patients during the winter season with higher 25-OHD
levels were more likely to develop acute lung injury (odds ratio 1.68, 95% confidence interval of 1.05 to 2.69,
P = 0.03). This association did not hold for the trauma cohort in either season. Sepsis and trauma patients had a
lower risk of hospital mortality at higher 25-OHD levels but neither relationship reached significance. Higher
one-year mortality after trauma was associated with lower 25-OHD levels (HR 0.50, CI 0.35,0.72 P = 0.001).
Conclusions: Serum 25-OHD measured early after admission to intensive care is not associated with the
development of acute lung injury, hospital or one-year mortality in critically ill patients with sepsis although lower
25-OHD levels were associated with higher one-year mortality in patients with severe trauma.
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Epidemiologic and biologic evidence supports a pivotal
role for vitamin D in health and disease [1-9]. Serum vita-
min D levels (as reflected by the serum concentration of
25-OHD) in the lowest quartile (< 45 nmol/L) are associ-
ated with excess all-cause mortality in the general popula-
tion. In a meta-analysis of randomized controlled trials in* Correspondence: Lorraine.ware@vanderbilt.edu
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in any medium, provided the original work is pwhich vitamin D was administered for any health condi-
tion, supplementation with standard doses reduced overall
mortality [10], an observation substantiated by a recent
Cochrane review [11]. Biologic data reinforce these obser-
vations [9]. Specifically, vitamin D and its receptor exhibit
key anti-inflammatory [12], membrane-stabilizing [13]
and anti-microbial properties [14] at barrier sites such as
the gut [15], lung [16] and skin [17].
In critical illness, vitamin D deficiency is prevalent,
[18,19] has been associated with increased length of ICU
stay [20] and adverse outcomes [21]. Low 25-OHD levels
measured within the year prior to intensive care admission
[22] but also at critical care initiation [23] are significantlyan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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Acute lung injury (ALI) and acute respiratory distress syn-
drome (ARDS) are syndromes of acute respiratory failure
occurring in the setting of common clinical conditions
including sepsis and trauma. It is still not understood
why some but not all patients at risk develop ALI/ARDS
[24]. Several features of the pathogenesis of ARDS, in-
cluding the central role of innate immunity, inflamma-
tion and the presence of increased lung endothelial and
epithelial permeability [25], suggest a candidate role for
vitamin D in modulating its development. Vitamin D’s
anti-inflammatory properties [26], pervasive role in endo-
thelial [27] and epithelial barrier functions [16] and poten-
tial to augment innate immunity [14] make it an important
avenue to explore in the pathogenesis of ALI.
We hypothesized that lower 25-OHD levels at the on-
set of critical illness would be associated with the devel-
opment of ALI/ARDS in two distinct populations at
high risk for ALI/ARDS: patients with severe sepsis and
patients with severe trauma. To test this hypothesis we
measured serum 25-OHD levels early in the course of
critical illness in two nested, parallel, case-control stud-
ies: patients with severe sepsis with or without ALI/
ARDS; and patients with severe trauma with or without
ALI/ARDS.
Methods
Study design and patients
Cases and controls were selected from the Validating
Acute Lung Injury biomarkers for diagnosis (VALID)
study. VALID is a single-center 2,500 patient observa-
tional cohort study of critically ill patients at high-risk for
ALI/ARDS [28,29], enrolling since 2006. Patients were re-
cruited from medical, surgical, cardiac and trauma ICUs
at Vanderbilt University Medical Center. All ICU patients
mechanically ventilated > 12 hours were eligible for en-
rollment. Patients were excluded if they were < 18 years of
age, were in any other ICU for > three days, had cardiac
arrest before enrollment, or if they were expected to be
transferred out of ICU by day two. Patients were also ex-
cluded if they were admitted for an uncomplicated over-
dose, routine postoperative admission after cardiothoracic
surgery or if they had a history of severe chronic lung dis-
ease. Comprehensive clinical data were obtained including
the Acute Physiology and Chronic Health Evaluation II
(APACHE II) score [30], Injury Severity Score (ISS) [31],
daily phenotyping for sepsis [32], organ failure [33] and
ALI/ARDS using the American European Consensus
Conference definitions [34]. Severe trauma was defined
as an ISS score > 15. Non-pulmonary organ failures
were assessed by Brussels scoring [33]. Informed con-
sent was obtained from an available surrogate or the
participants themselves when possible. A waiver of
consent was also granted due to the minimal risk forstudy participants. The Institutional Review Board at
Vanderbilt approved the study protocol.
For the sepsis study, cases were defined as patients
with severe sepsis at the time of enrollment meeting
consensus criteria for ALI/ARDS during the first four
days in the ICU after enrollment. Controls were patients
with severe sepsis at the time of enrollment not meeting
consensus criteria for ALI/ARDS during the first four
days in the ICU. For the trauma study, cases were de-
fined as patients with severe trauma who met consensus
criteria for ALI/ARDS during the first four days in the
ICU. Controls were patients with severe trauma who did
not meet consensus criteria for ALI/ARDS during the
first four days in the ICU. In both studies, controls were
matched one to one to cases for severity of illness using
the APACHE II for the sepsis cohort and the ISS for the
trauma cohort. Cases and controls were also matched
for age (within five years), length of daylight at enroll-
ment (within one hour) and ethnicity - all factors that
may affect 25-OHD levels [35]. We identified 480 suit-
able patients from VALID: 120 cases with ALI/ARDS
and sepsis, 120 cases with ALI/ARDS and trauma and a
matching number of sepsis (120) and trauma (120) con-
trols. One patient from the trauma cohort had no serum -
its matched pair was therefore removed leaving a total of
478 eligible patients (119 trauma cases and 119 trauma
controls). Of these, one trauma patient and one sepsis pa-
tient did not have sufficient serum for vitamin D analysis
(see Additional file 1).
Vitamin D measurement
Samples were obtained the morning after ICU admis-
sion, processed within one hour of collection, centri-
fuged and stored at -80°C until further analysis. For
quantitative determination of 25-OHD we used a Food
and Drugs Administration approved [35], direct, com-
petitive chemiluminescence immunoassay (CLIA) using
the DiaSorin LIASON 25-OHD total assay (Heartland
Assays, Ames, IA, USA) [36]. Serum 25-OHD was mea-
sured in duplicate.
Definition of deficiency
Sufficiency was defined as 25-OHD > 75 nmol/L, insuffi-
ciency 50 to 75 nmol/L and deficiency < 50 nmol/L [37].
Exposure, covariates and outcomes
The primary exposure variable was the serum 25-OHD
level measured on the morning of ICU day two. Multiple
covariates were selected a priori including age, gender,
diabetes, smoking status and season for their potential
confounding effects on risk of ALI and modulation of
vitamin D levels. Levels of 25-OHD in the tables are pre-
sented in nmol/L.
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in the first four days of admission to the ICU, which was
the time frame for intensive clinical phenotyping for
ALI/ARDS in the VALID study. Hospital mortality and
all-cause one-year mortality were pre-specified second-
ary end-points.
Statistical analysis
We fit multivariable conditional logistic regression models
using log transformed 25-OHD to investigate the effects
of 25-OHD on our primary and secondary outcomes.
Pre-specified exploratory variables included age, gender,
smoking status, diabetes and season. As an additional ana-
lysis, we a priori stratified patients into two seasons, aTable 1 Baseline characteristics of patients from the sepsis co
Characteristic N Cases
(n = 120)
Agec (IQR) 240 59.3 (53.2





Diabetes (%) 240 31 (26)
Summer season (%) 240 34 (28)
Day length hours (IQR)c 240 12.0 (10.6
APACHE II Score (IQR)c 240 28 (23, 32






Days of ICU stay (IQR) 240 9 (6,15)
Hospital mortality (%) 240 30 (25)
One-year mortality (%) 240 66 (55)
Risk factors for ALI/ARDS 240
Non-pulmonary sepsis 55 (46)
Pneumonia 39 (33)
Aspiration 24 (20)
Other or Noned 1 (1)
Patients on ventilator 89 (74)
25-OHD (nmol/L) (IQR) 239 45.8 (29.9
Vitamin D status (%) 239
Deficiency (< 50 nmol/L) 72 (60)
Insufficiency (50 to 75 nmol/L) 32 (27)
Sufficiency (> 75 nmol/L) 16 (13)
Data given as median with interquartile range (IQR) or frequency with (%) of patien
N is the number of non-missing values.
aWilcoxon signed rank test; bMcNemar’s test; cMatched; dOther or None (pancreatitisummer season (21 June to 21 Dec) and a winter season
(21 Dec to 21 June) and thus included an interaction term
for season in our model to investigate the season-specific
effects on our primary outcome of interest (ALI/ARDS).
We used Cox proportional hazard models to investi-
gate the effects of 25-OHD on the secondary outcomes -
hospital mortality and one-year mortality. In the trauma
cohort, ISS was missing for 34 subjects. A multiple
imputation method with ten imputation datasets was
used to accurately estimate the parameters and standard
errors of risk factors. All statistical inferences were
assessed at a two-sided 5% significant level. All summary
statistics, graphics, and models were generated using R
version 2.13.1 statistical software.hort
Controls Combined P-value
(n = 120) (n = 240)
, 65.7) 59.3 (52.7, 65.7) 59.3 (53.2, 65.7) 0.885a
56 (47) 109 (45) 0.791b
0.505b
33 (29) 73 (32)
40 (35) 84 (36)
41 (36) 74 (32)
47 (39) 78 (32) 0.045b
35 (29) 69 (29) 1b
, 13.6) 12.0 (10.6, 13.5) 12.0 (10.6, 13.6) 0.655a
.2) 28 (23, 32.2) 28 (23, 32.2) NA
0.753a
24 (20) 39 (16)
45 (38) 105 (44)
39 (32) 78 (32)
9 (8) 13 (5)
3 (2) 5 (2)
6 (4,10) 7 (4,14) 0.008a
31 (26) 61 (25) 1b
71 (59) 137 (57) 0.614b
< 0.001b
70 (60) 125 (53)
22 (19) 61 (26)
8 (7) 32 (14)
16 (14) 17 (16)
71 (59) 160 (67) 0.016b
, 60.8) 39.0 (25.0, 56.9) 43.2 (27.6, 58.8) 0.123a
0.358b
82 (69) 154 (64)
26 (22) 58 (24)
11 (9) 27 (11)
ts.
s, multiple transfusions, trauma).
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data in determining appropriate sample size for this
study [19,38]. Based on a reconstructed distribution with
mean 35 to 38 nmol/L and a standard deviation of ap-
proximately 22, a sample of size of 240 (120 cases and
120 controls) has a power of 90% (with type I error rate
of 5%) to detect a difference equivalent to approximately
40% to 50% of a within-group standard deviation using a
simple t-test. Additionally, with a total sample size of ap-
proximately 240 for each cohort, we included five variables
in our multivariable model without risk of over-fitting. To
determine the association of 25-OHD levels with our pri-
mary (ALI/ARDS) and secondary (hospital and one-year
mortality) outcomes in our regression models, we opted
to compare 25-OHD levels at fixed points on a continuous
scale: third (upper) and first (lower) quartiles.
Results
Sepsis cohort
Patient characteristics and vitamin D status are summarized
in Table 1. Cases and controls were well matched for
baseline characteristics but differed on other important
characteristics such as presence of diabetes, use of minute
ventilation and risk factors for ALI/ARDS (Table 1). Eighty-
eight percent of patients with severe sepsis had vitamin D
deficiency or insufficiency (serum 25-OHD < 75 nmol/L).
Median serum 25-OHD concentration was 43.2 nmol/L.
There was no significant difference in serum 25-OHD
levels between ALI cases and controls (median 45.8 ver-
sus 39.0 nmol/L, P = 0.12) (Table 1 and Figure 1).
A higher serum level of 25-OHD in patients admitted
during winter months was associated with developing
ALI/ARDS; odds ratio (OR) was 1.68 (95% CI 1.054 toFigure 1 Box plot summary of 25-hydroxyvitamin D (25-OHD) levels b
significantly different between patients with or without acute lung injury/a
medians, boxes encompass the 25th to 75th percentile and error bars enco2.69), (P = 0.03) for the upper (58.3 nmol/L) compared
to the lower quartile (27.6 nmol/L). During summer
months we observed no association between 25-OHD
levels and development of ALI/ARDS; OR 1.16 (95% CI
0.589 to 2.25), (P = 0.66) (Table 2 and Figure 2).
When all patients with severe sepsis were considered
together (both cases and controls) patients with 25-
OHD levels at the highest quartile (58.3 nmol/L) had a
hazard ratio of 0.74 (95% CI 0.53 to 1.05) for hospital
mortality compared to the lowest quartile (27.6 nmol/L),
a result that was not significant (P = 0.09) (Table 3). Pa-
tient survival time up to one year was also not associated
with 25-OHD levels (P = 0.24) (Table 4).
Trauma cohort
Trauma patient characteristics are summarized in Table 5.
The trauma cohort was well matched for baseline and sec-
ondary characteristics. The median serum 25-OHD level
in trauma patients was 53.4 nmol/L. Eighty-one percent of
trauma patients were either vitamin D insufficient or defi-
cient. There was no significant difference in serum 25-
OHD levels between trauma ALI and non-ALI groups
(54.9 versus 50.8 nmol/L, P = 0.30) (Figure 1) nor was any
statistically significant relationship detected on multivari-
able analysis (Table 2 and Figure 3).
In the trauma cohort, 25-OHD levels were also not sig-
nificantly associated with time to hospital mortality - haz-
ard ratio 0.59 (95% CI 0.3 to 1.20), (P = 0.14) (Table 3).
On the other hand, 25-OHD levels significantly predicted
all-cause, one-year mortality from trauma (P = 0.001),
hazard ratio 0.5 (95% CI 0.35 to 0.72) (Table 4.) Age was
also significantly associated with hospital and all-cause
mortality from trauma with hazard ratios of 1.07 (95% CIy cohort and case-control status. Twenty-five-OHD levels were not
cute respiratory distress syndrome (ALI/ARDS). Horizontal bars represent
mpass the 10th to 90th percentile.
Table 2 Conditional logistic regression analysis for risk of acute lung injury/acute respiratory distress syndrome
(ALI/ARDS) in the sepsis cohort (left) and trauma cohort (right)
Characteristics Sepsis cohort Trauma cohort
OR 95% CI P-value OR 95% CI P-value
Age (increment of one year) 0.98 0.84 to 1.15 0.805 0.93 0.77 to 1.13 0.482
Gender (male versus female) 1.14 0.63 to 2.04 0.668 0.81 0.39 to 1.71 0.586
Diabetes (yes versus no) 0.61 0.33 to 1.12 0.110 1.10 0.39 to 3.08 0.854
Smoking (never versus ever) 1.63 0.86 to 3.11 0.136 1.15 0.54 to 2.41 0.720
Vitamin D levels (summer)a 1.16 0.60 to 2.25 0.663 1.25 0.55 to 2.86 0.591
Vitamin D levels (winter)a 1.68 1.05 to 2.69 0.029 1.23 0.74 to 2.06 0.425
Season (winter versus summer)b 1.36 0.49 to 3.75 0.553 0.61 0.20 to 1.86 0.385
Abbreviations: OR odds ratio, CI confidence interval.
athird versus first quartile; sepsis cohort: 58.9 versus 27.6 nmol/L; trauma cohort: 71.9 versus 37.2 nmol/L.
bvitamin D was fixed at median; sepsis cohort: 43.2 nmol/L; trauma cohort: 53.4 nmol/L.
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P < 0.001) respectively. All other variables had no sig-
nificant association with hospital or one-year mortality
in our models.
Discussion
In this case-control study of two ‘at risk’ populations for
ALI/ARDS, patients with severe sepsis or severe trauma,
vitamin D levels measured on the morning after ICU
admission were not associated with development of ALI/
ARDS. Furthermore, in a stratified analysis of patients
with sepsis during the winter season, higher rather than
lower vitamin D levels were associated with increased
risk for ALI/ARDS (P = 0.03). The biologic rationale for
this finding is uncertain. One potential explanation isFigure 2 Forest plot summary of logistic regression analysis for risk of
the sepsis cohort. Higher vitamin D levels in winter were associated with a h
2.69), (P = 0.03). OR (black dots) and the corresponding CIs (black lines) for thethat vitamin D physiology is complex. Higher vitamin D
levels may, in certain situations, paradoxically increase
the pathogen burden [39] leading to a worsening of pro-
inflammatory stress in the lung and thence to ALI/
ARDS. Another, more likely, interpretation for our pri-
mary findings is that low levels of vitamin D are not
associated with development of ALI/ARDS and are po-
tentially epiphenomena of severity and/or chronicity of
illness [40]. In the current study, when cases and con-
trols were rigorously matched for severity of illness
using APACHE II scores and other clinical characteris-
tics, no association between ALI/ARDS and 25-OHD
levels was apparent. This result was consistent across
two diverse patient groups and risk factors for ALI/
ARDS: severe sepsis and severe trauma.acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in
igher odds ratio (OR) for developing ALI/ARDS: OR 1.68 (95% CI 1.054 to
risk of ALI/ARDS for each covariate are shown.
Table 3 Survival analysis for hospital mortality in the sepsis cohort (left) and the trauma cohort (right)
Characteristics Sepsis cohort Trauma cohort
HR 95% CI P-value HR 95% CI P-value
Age (increment of one year) 1.02 1.00 to 1.05 0.100 1.04 1.01 to 1.08 0.019
Gender (male versus female) 1.19 0.67 to 2.12 0.552 1.16 0.37 to 3.62 0.794
Diabetes (yes versus no) 1.14 0.64 to 2.02 0.663 0.82 0.22 to 3.05 0.768
Smoking (never versus ever) 0.82 0.44 to 1.54 0.543 0.90 0.31 to 2.66 0.855
Vitamin D levelsa 0.74 0.53 to 1.05 0.092 0.59 0.30 to 1.19 0.140
Season (winter versus summer) 0.86 0.48 to 1.54 0.618 0.85 0.27 to 2.73 0.787
Abbreviations: HR hazard ratio, CI confidence interval.
athird versus first quartile; sepsis cohort: 58.9 versus 27.6 nmol/L; trauma cohort: 71.9 versus 37.2 nmol/L.
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vitamin D deficiency on organ and immune dysfunction
abounds [13,41] but evidence in the intensive care arena
is lacking. Jeng et al. [19] found that both septic and non-
septic ICU patients had low vitamin D levels without any
demonstrable differences in levels between groups sug-
gesting that critical illness per se is preceded by or results
in low vitamin D levels. On the other hand, Braun et al.
[22] in a much larger 2,399 patient cohort provide evi-
dence for an association of vitamin D deficiency with mor-
tality in the ICU. They showed an association of ICU,
hospital, 30, 60, 90 and 365-day mortality in patients with
the lowest levels of pre-admission (up to one year prior to
admission) vitamin D levels. A subsequent study by the
same group [23] examined peri-admission (seven days
prior to and/or seven days following ICU admission) 25-
OHD levels, and likewise reported a positive association
between 25-OHD deficiency and 30-day mortality. Sec-
ondary end-points of 90 and 365-day mortality also were
associated with peri-admission vitamin D deficiency.
In this study, sepsis patients with increased vitamin D
levels demonstrated a non-significant trend to reduced
hospital mortality (P = 0.09) that did not persist to one-
year (P = 0.24). By comparison, Braun et al. [22] obtained
25-OHD samples up to a year prior to ICU admission po-
tentially deterring from their predictive power at the time
of critical illness. To dispel this limitation a follow-up
study [23] examined 25-OHD levels around the time of
critical care initiation and observed a similar association.Table 4 Survival analysis for delayed, one-year mortality in th
Characteristics Sepsis cohort
HR 95% CI
Age (increment of one year) 1.02 1.00 to 1.04
Gender (male versus female) 1.26 0.90 to 1.78
Diabetes (yes versus no) 1.04 0.72 to 1.49
Apache II/ISS scoreb 1.35 1.05 to 1.73
Vitamin D levels (high versus low)a 0.87 0.68 to 1.10
Abbreviations: HR hazard ratio, CI confidence interval.
athird versus first quartile; sepsis cohort: 58.9 versus 27.6 nmol/L; trauma cohort: 71
bthird versus first quartile; sepsis cohort: Apache II score, 32.2 versus 23; trauma cohHowever, the time span from measurement to critical care
initiation was relatively large (14 days) as opposed to the
narrower 36 hours defined in our study. Moreover, neither
analysis included information on important co-variates
that may affect 25-OHD levels such as smoking or aggre-
gate scores of chronic disease and physiologic perturb-
ation such as APACHE II score that may affect mortality
risk [30]. In the current study we elected to control for se-
verity of illness because it is likely to impact negatively
both on vitamin D levels and mortality. In many patients,
relative malnutrition and periods of physical inactivity pre-
cede critical illness. Second, a dilutional effect may occur
owing to vigorous fluid resuscitation at the time of critical
illness [42]. While we did not control for volume of resus-
citation in our analysis, matching by severity of illness
(APACHE II or ISS scores) should imply a similar resus-
citation burden between and across cohorts, thereby
minimizing the potentially confounding effects of acute
fluid loading.
Interestingly, lower 25-OHD levels were significantly as-
sociated with one-year mortality (P < 0.001) in trauma pa-
tients, the first time this association has been observed.
Very little has been published regarding long term out-
comes from major trauma. A recent study implicated age
older than 65, hospitalization greater than 28 days and un-
intentional falls as risk factors for delayed one-year mor-
tality following trauma [43]. Our data also identified older
age to be a significant risk factor for delayed mortality
after trauma (Table 4). Older age and unintentional fallse sepsis cohort (left) and the trauma cohort (right)
Trauma cohort
P-value HR 95% CI P-value
0.023 1.06 1.04 to 1.08 0.023
0.181 2.04 1.00 to 4.18 0.051
0.841 0.63 0.28 to 1.45 0.280
0.019 1.04 0.68 to 1.60 0.849
0.240 0.50 0.35 to 0.72 < 0.001
.9 versus 37.2 nmol/L.
ort: ISS score, 36.0 versus 23.5.
Table 5 Basline characteristics of patients from the trauma cohort
Characteristic N Cases Controls Combined P-value
(n = 119) (n = 119) (n = 238)
Agec 238 44.7 (30.8, 58.2) 46.8 (29.8, 56.8) 46.2 (30.4, 57.8) 0.651a
Female gender (%) 238 35 (29) 33 (28) 68 (29) 0.883b
Smoking (%) 194 0.370b
Never 36 (35) 30 (33) 66 (34)
Former 8 (8) 3 (3) 11 (6)
Current 60 (58) 57 (63) 117 (60)
Diabetes (%) 238 16 (13) 16 (13) 32 (13) 1b
Summer season (%) 238 48 (40) 48 (40) 96 (40) 1b
Day length hours (IQR)c 238 12.6 (10.8, 13.8) 12.6 (10.7, 13.9) 12.6 (10.8, 13.9) 0.331a
APACHE II score (IQR) 238 26.0 (21.5, 29.5) 24.0 (19.0, 27.5) 25.0 (20.0, 29.0) 0.078a
ISSc (IQR) 204 29.0 (24.0, 35.8) 29.0 (22.0, 36.0) 29.0 (23.5, 36.0) 0.993a
Number of non-pulmonary organ failures (%) 238 0.645a
0 42 (35) 49 (41) 91 (38)
1 61 (51) 52 (44) 113 (47)
2 13 (11) 15 (13) 28 (12)
3 3 (3) 3 (3) 6 (3)
Days of ICU stay (IQR) 238 11.0 (7.0, 18.5) 9.0 (5.0, 16.0) 10.0 (6.0, 18.0) 0.155a
Hospital mortality (%) 238 10 (8) 13 (11) 23 (10) 0.663b
One-year mortality (%) 238 20 (17) 25 (21) 45 (19) 0.511b
Risk factors for ALI/ARDS 235
Severe trauma 116 (99) 116 (99) 232 (99)
Aspiration 2 (2) 0 (0) 2 (1)
Other or Noned 0 (0) 1 (1) 1 (1)
Patients on ventilator 115 (97) 115 (97) 230 (97) 1b
25-OHD (nmol/L) (IQR) 237 54.9 (38.3, 72.5) 50.8 (36.9, 69.8) 53.4 (37.2, 71.9) 0.302a
Vitamin D Status (%) 237 0.606b
Deficiency (< 50 nmol/L) 54 (45) 59 (50) 113 (48)
Insufficiency (50 to 75 nmol/L) 37 (31) 38 (32) 75 (32)
Sufficiency (> 75 nmol/L) 28 (24) 21 (18) 49 (21)
Data given as median and interquartile range (IQR) or frequency with (%) of patients.
N is the number of non-missing values.
aWilcoxon signed rank test; bMcNemar’s test; cMatched; dOther or None (multiple transfusions).
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levels though the potential for residual confounding re-
mains. For example, confounding by BMI, for which we
do not have data in our study, is a possible explanation
for this result. A higher BMI correlates both with worse
outcomes [44] from trauma and is associated with lower
25-OHD levels [45]. However, cases and controls for
this study were matched with our primary end-point
(ALI/ARDS) in mind and not mortality and as such this
result is a novel and potentially hypothesis-generating
observation.
The study has some limitations. Study design allowed
us to control for severity of illness but the study was not
powered for mortality analysis and the case-control de-
sign may limit the generalizability of the findings. Asecond limitation is that we did not measure serial vita-
min D levels and therefore could not correlate vitamin
D kinetics during critical illness to acute decompensa-
tions or improvements in clinical status. Higgins et al.
[46] recently showed a mean reduction in 25-OHD
levels during critical illness of 2.6 mmol/L by day three
and 6.0 mmol/L by day ten. Reid et al. [47] similarly ob-
served a mean diminution of 2.7 mmol/L in 25-OHD
levels 48 hours after an acute surgical insult for elective
hip or knee surgery together with a mean reciprocal
increase in CRP from 5 to 116 mg/ml - a situation that
may pertain to all fat-soluble vitamins [48]. They con-
clude that 25-OHD is likely a negative acute phase react-
ant with low levels persisting for several months after an
inflammatory insult.
Figure 3 Forest plot of logistic regression analysis for risk of acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in the
trauma cohort. Vitamin D levels were not associated with risk of ALI/ARDS in severe trauma. Odds ratio (black dots) and the corresponding
confidence intervals (black lines) for the risk of ALI/ARDS for each covariate are shown.
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control for vitamin D binding protein (VDBP). Falls in
this protein during critical illness could impact on 25-
OHD levels. However, the association of vitamin D with
its binding protein is complex [49] and non-linear. Fur-
thermore, higher levels of VDBP may limit the bioavail-
ability of the free and bioactive vitamin [50]. Because of
this complexity, future studies of vitamin D deficiency
and outcomes in ICU may wish to measure both serial
vitamin D levels and VDBP.
Additionally, we were also unable to control for pre-
hospital use of calcium and vitamin D that could be a
potential confounder of serum 25-OHD levels. However,
this information can be difficult to obtain even prospect-
ively in critically ill patients and hence is absent from
the majority of studies of vitamin D in critical illness
[19,22,23]. We have found only one small study with in-
formation on calcium/vitamin D supplementation [38].
In this study, only 13% of the total cohort was on sup-
plements but 7% had end-stage renal failure, a patient
group commonly on supplementation. Moreover, sup-
plementation in this study was predictive of vitamin D
deficiency supporting the hypothesis that most patients
on supplements had concomitant renal failure with
hypovitaminosis D. In addition, with a median age in the
mid 40s, it is unlikely that patients in our trauma cohort
were on vitamin D supplementation. Finally, we did not
obtain data and, therefore, could not control for transfu-
sion requirements, which may influence ARDS risk [51]
and potentially be associated with vitamin D levels.
There is however no evidence on the stability of fat-soluble vitamins in transfused blood and matching by
trauma severity (ISS) would plausibly suggest similar
transfusion schedules.
Our study has several strengths. To our knowledge, it
is the first study to investigate the association of ALI/
ARDS in critical illness with 25-OHD levels. We report
a consistent lack of association between lower 25-OHD
levels and risk of ALI/ARDS across two cohorts of pa-
tients who were carefully matched for age, gender, smok-
ing status and severity of illness with distinct risks for
ALI/ARDS. Both cohorts mirror each other in suggest-
ing that patients with ALI/ARDS have slightly elevated
25-OHD levels in comparison to their control counter-
parts lending internal validity to the findings. The study
population is broad, rigorously phenotyped and repre-
sentative of a critical care population in terms of disease
acuity (based on APACHE II and ISS scores), basic demo-
graphics, the spectrum of ICUs (cardiac, medical, surgical
and trauma) and hospital mortality across both cohorts.
Furthermore, blood was sampled at clear and uniform
time-points, early in the course of critical illness allowing
for a consistent analysis of the relationship between the
exposure, 25-OHD levels, and the outcome of interest,
ALI/ARDS.
Although the findings of this study are not definitive,
they do call into question the hypothesis that vitamin D
supplementation might help reconstitute immune, endo-
thelial, epithelial and thence organ function across a
variety of clinical and biological end-points [52]. Indeed,
the Institute of Medicine’s recent report [53] stated that
there was insufficient evidence at present to recommend
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health. Prospective studies of supplementation in critical
illness are awaited before any definitive conclusions can
be drawn. However recent negative supplementation
studies in respiratory [54,55] and cardiovascular disease
[56] tend to support the Institute of Medicine’s position.
Conclusions
This case-control study of 478 patients with sepsis or
trauma showed no association between lower 25-OHD
levels and development of ALI/ARDS in stringently
matched cases and controls. Contrary to our initial hypoth-
esis, we noted the unexpected finding of higher 25-OHD
levels associated with ALI/ARDS in winter in the sepsis co-
hort. In a secondary analysis, we discerned no associations
between lower 25-OHD levels and hospital or delayed
mortality with the exception of an association of higher 25-
OHD levels with a lower risk of one-year mortality from
trauma. While the present study does not preclude a po-
tential beneficial effect of vitamin D supplementation in se-
vere sepsis, our findings suggest that any potential benefit
is not likely to be related to prevention of ALI/ARDS; a
hitherto unsuspected mortality benefit may, however, exist
for patients with severe trauma.
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